Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific, Invitrogen, Syngen, AnaSpec

Premium
Thermo Fisher Scientific unveiled version 8.0 of the Nautilus laboratory information management system this week. The company said the update is the most comprehensive to Nautilus since the product was commercialized in 1998.
 
Among the improvements, according to Thermo Fisher, is greater ease of use from organizing data to searching and log-in; a new cut-and-paste operation allowing users to copy workflow nodes rather than having to rebuild them; and the use of .NET technology that gives users greater interaction and flexibility with plates.
 

 
Invitrogen this week launched its ProtoArray Human Protein Microarray version 4.0. The array “enables customers to screen biological samples or labeled probe of interest against 8,000 unique human proteins in a single, rapid experiment,” the company said in a statement. 
 

 
Syngene this week introduced Dyversity 4, an automated multifunctional image analyzer. The instrument comprises a high resolution, 16-bit CCD camera inside a light tight darkroom integrated to a PC containing Syngene image capture and analysis software, the company said in a statement.
 

 
 
AnaSpec launched this week 11 research-ready plant peptides called phytochelatins, a class of heavy metal-detoxifying peptides. More information about them can be found here.
 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.